Tianjin Medical University Cancer Institute & Hospital Reports Fin dings in Cancer (Targeting treatment resistance: unveiling the potential of RNA methylation regulators and TG-101,209 in pancancer neoadjuvant therapy

扫码查看

原文链接

NETL
NSTL

外文摘要：By a News Reporter-Staff News Editor at Robotics & Machine Learning DailyNews Daily News – New research on Cancer is the subject of a report. According to news reporting out ofTianjin, People’s Republic of Ch ina, by NewsRx editors, research stated, “Tumor recurrence and mortalityrates r emain challenging in cancer patients despite comprehensive treatment. Neoadjuvan t chemotherapyand immunotherapy aim to eliminate residual tumor cells, reducing the risk of recurrence.”

外文关键词：

TianjinPeople’s Republic of ChinaAsi aCancerChemotherapyCombined Modality TherapyCyborgsDrugs and TherapiesEmerging TechnologiesGeneticsHealth and MedicineImmunotherapyMachine L earningNeoadjuvant TherapyOncologyPharmaceuticalsRisk and Prevention

出版年：

2024

Robotics & Machine Learning Daily News

ISSN：

年,卷(期)：2024.(Sep.4)